Literature DB >> 9760982

Rathke's cleft cyst.

S Nagasaka1, C Kuromatsu, S Wakisaka, K Kitamura, T Matsushima.   

Abstract

Two cases of Rathke's cleft cyst which produced symptoms of compression of the optic chiasm are described. The first case has been followed for five years since the operation. No evidence of recurrence has been noticed. The prognosis after a partial removal of the cyst wall seems to be good with this lesion. In the second case, there was clinical and laboratory evidence of hypopituitarism and the CT scan revealed suggestive findings to differentiate the cyst from a pituitary adenoma.

Entities:  

Mesh:

Year:  1981        PMID: 9760982     DOI: 10.1016/0090-3019(81)90179-8

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  5 in total

1.  Preoperative diagnosis of Rathke's cleft cyst.

Authors:  H Ito; K Shoin; W Z Hwang; H Oonishi; T Hasegawa; S Yamamoto
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

2.  CT findings in symptomatic Rathke's cleft cysts of the pituitary gland. Report of three cases.

Authors:  J L Dietemann; J F Bonneville; F Buchheit; F Cattin; N Heldt; A Wackenheim
Journal:  Neuroradiology       Date:  1983       Impact factor: 2.804

3.  Symptomatic Rathke's cleft cyst in an old patient. Case report.

Authors:  T Kojima; Sh Waga
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216

Review 4.  Rathke's cleft cyst rupture as potential initial event of a secondary perifocal lymphocytic hypophysitis: proposal of an unusual pathogenetic event and review of the literature.

Authors:  Jens Schittenhelm; Rudi Beschorner; Tsambika Psaras; David Capper; Thomas Nägele; Richard Meyermann; Wolfgang Saeger; Jürgen Honegger; Michel Mittelbronn
Journal:  Neurosurg Rev       Date:  2008-02-06       Impact factor: 3.042

5.  A case of Rathke's Cleft Cyst inflammation presenting with diabetes insipidus.

Authors:  J W Yoon; S K Jo; D R Cha; W Y Cho; H K Kim
Journal:  Korean J Intern Med       Date:  2001-06       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.